IFN-α Boosting of Mycobacterium bovis Bacillus Calmette Güerin-Vaccine Promoted Th1 Type Cellular Response and Protection against M. tuberculosis Infection

Successive Intramuscular Boosting with IFN-Alpha ProtectsMycobacterium bovisBCG-Vaccinated Mice againstM. lepraemuriumInfection

(2015) G. G. Guerrero et al.   Biomed Research International

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

(2014) Katrin D. Mayer-Barber et al.   NATURE

The Immune Response in Tuberculosis

(2013) Anne O'Garra et al.   Annual Review of Immunology

Type I Interferon Suppresses Type II Interferon-Triggered Human Anti-Mycobacterial Responses

(2013) R. M. B. Teles et al.   SCIENCE

Role of innate cytokines in mycobacterial infection

(2011) A M Cooper et al.   Mucosal Immunology

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

(2010) Matthew P. R. Berry et al.   NATURE

Boosting with mycobacterial heparin-binding haemagglutinin enhances protection of Mycobacterium bovis BCG-vaccinated newborn mice against M. tuberculosis

(2010) Gloria G. Guerrero et al.   VACCINE

Cell-Mediated Immune Responses in Tuberculosis

(2009) Andrea M. Cooper   Annual Review of Immunology

Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans

(2009) Robert B. Couch et al.   VACCINE

IFN-β improves BCG immunogenicity by acting on DC maturation

(2008) Elena Giacomini et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Heterologous Boosting of Recombinant Adenoviral Prime Immunization With a Novel Vesicular Stomatitis Virus–vectored Tuberculosis Vaccine

(2008) Elizabeth K Roediger et al.   MOLECULAR THERAPY